Covered recipient · General Payments record
ROBERT F SWORDS
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2022
$281.36
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $121.89 | 18 |
| Education | $30.12 | 2 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $121.89 | 18 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.12 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.81 | 01/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892483999 | CMS |
| ABBVIE INC. | $4.76 | 01/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484001 | CMS |
| ABBVIE INC. | $12.20 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484003 | CMS |
| ABBVIE INC. | $5.83 | 02/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484005 | CMS |
| ABBVIE INC. | $8.25 | 03/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484007 | CMS |
| ABBVIE INC. | $1.10 | 03/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484009 | CMS |
| ABBVIE INC. | $2.19 | 04/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484011 | CMS |
| ABBVIE INC. | $5.30 | 04/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484013 | CMS |
| ABBVIE INC. | $10.16 | 04/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484015 | CMS |
| ABBVIE INC. | $11.26 | 04/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484017 | CMS |
| ABBVIE INC. | $9.66 | 05/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484019 | CMS |
| ABBVIE INC. | $5.75 | 05/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484021 | CMS |
| ABBVIE INC. | $3.75 | 05/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484023 | CMS |
| ABBVIE INC. | $3.88 | 06/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484025 | CMS |
| ABBVIE INC. | $4.62 | 07/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484027 | CMS |
| ABBVIE INC. | $8.89 | 07/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484029 | CMS |
| ABBVIE INC. | $1.12 | 09/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484031 | CMS |
| ABBVIE INC. | $5.36 | 10/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892484033 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.06 | 11/15/2022 | Education | Undisputed | 01/23/2026 | 955796015 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.06 | 12/20/2022 | Education | Undisputed | 01/23/2026 | 955796019 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.